Effectiveness of PEMF in Patients With Chronic Radicular Pain Due to Lomber Disc Herniation

August 7, 2019 updated by: Birkan Sonel Tur

Effectiveness of Pulse Electromagnetic Field Therapy (PEMF) on Pain, Functional Status, and Quality of Life in Patients With Chronic Radicular Pain Due to Lumbar Disc Herniation

The aim of this study is to investigate the effectiveness of pulse magnetic field therapy on pain, functional status, and quality of life in patients with chronic radicular pain due to lumbar disc herniation.

Study Overview

Detailed Description

Pulsed Electromagnetic Field Therapy (PEMF) is a non-invasive, painless treatment for various injuries, bone related conditions and pains. However, further studies on PEMF effects on low back and radicular pain is needed due to lack of studies in this area.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 61 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18-65
  • Unilateral radicular pain for at least 3 months
  • Severity of radicular pain with Visual Analog Score of at least 4/10
  • Written informed consent

Exclusion Criteria:

  • Pregnancy or lactation
  • Cardiac pacemaker, or any metal implants or electronic devices anywhere in the body
  • History of surgery or algological procedure of the lumbar region
  • Physical therapy within the last year due to back pain
  • Previous PEMF treatment
  • Malignancy or suspicion
  • Polyneuropathy (diabetic or other)
  • Connective tissue disease
  • Presence of inflammatory joint pain
  • Fibromyalgia
  • Presence of open surface wound
  • Tuberculosis, mycosis, or viral disease
  • Presence of pain in another region of the body with higher severity than radicular back pain
  • Use of drugs other than paracetamol-derivative simple analgesics (Nonsteroidal Aanti inflammatuar, central effective, or narcotic analgesics), or less than three weeks since the discontinuation of these drugs
  • Advanced mood disorder
  • Radiographic evidence of Grade 2 spondylolisthesis, presence of spinal instability, and advanced degenerative spondylarthrosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Pulsed electromagnetic field (PEMF) treatment Group
Group received routine hot pack, Transcutaneous electrical nerve stimulation (TENS) and PEMF treatment.
Sham Comparator: Sham PEMF treatment Group
Group received routine hot pack, TENS and sham PEMF treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
10 cm Pain Visual Analogue Scale (VAS)
Time Frame: 3 weeks
The patient is asked to indicate their perceived pain intensity along a 10cm horizontal line, where '0' represents 'no pain' and '10', 'unbearable pain'.
3 weeks
10 cm Pain Visual Analogue Scale (VAS)
Time Frame: one month after treatment
The patient is asked to indicate their perceived pain intensity along a 10 cm horizontal line, where '0' represents 'no pain' and '10', 'unbearable pain'.
one month after treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disability; Roland-Morris Disability Questionnaire (RMDQ)
Time Frame: 3 weeks
RMDQ has 24 yes/no questions. Scoring is between 0-24. A score of 0: no disability, score of >1 indicates disability.
3 weeks
Disability; Roland-Morris Disability Questionnaire (RMDQ)
Time Frame: One month after treatment
RMDQ has 24 yes/no questions. Scoring is between 0-24. A score of 0: no disability, score of >1 indicates disability.
One month after treatment
Nottingham Health Profile (NHP)
Time Frame: 3 weeks

Nottingham Health Profile (NHP) is a questionnaire designed to measure a patient's view of their own health status, in a number of areas.

The NHP consists of two parts. The first part focuses on health and comprises 38 items which deal with pain, energy, sleep, mobility, emotional reaction and social isolation. All questions have only yes/no answer options and each section score is weighted. The higher the score, the greater the number and severity of problems. The highest score in any section is 100.

3 weeks
Nottingham Health Profile (NHP)
Time Frame: One month after treatment

Nottingham Health Profile (NHP) is a questionnaire designed to measure a patient's view of their own health status, in a number of areas.

The NHP consists of two parts. The first part focuses on health and comprises 38 items which deal with pain, energy, sleep, mobility, emotional reaction and social isolation.All questions have only yes/no answer options and each section score is weighted. The higher the score, the greater the number and severity of problems. The highest score in any section is 100.

One month after treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2016

Primary Completion (Actual)

February 28, 2018

Study Completion (Actual)

March 31, 2018

Study Registration Dates

First Submitted

July 12, 2019

First Submitted That Met QC Criteria

August 7, 2019

First Posted (Actual)

August 8, 2019

Study Record Updates

Last Update Posted (Actual)

August 8, 2019

Last Update Submitted That Met QC Criteria

August 7, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lumbar Disc Herniation

Clinical Trials on TENS

Subscribe